SPY321.59+2.67 0.84%
DIA268.30+1.71 0.64%
IXIC10,545.71+57.13 0.54%
新闻
AGEN
--
0.00%
--
Agenus (AGEN) is a Great Momentum Stock: Should You Buy?
Does Agenus (AGEN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks · 2天前
明星药物PD-1竞争提速 专家:已进入市场销售关键期
证券日报 · 2天前
With Multiple Late Stage Cancer Therapies, Agenus Inc. Offers The Best Risk/Reward Profile In Biotechnology
Seeking Alpha - Article · 6天前
Is Agenus Inc (AGEN) A Good Stock To Buy?
Insider Monkey · 07/05 20:40
What Is The Ownership Structure Like For Agenus Inc. (NASDAQ:AGEN)?
Simply Wall St. · 07/03 15:25
Moving Average Crossover Alert: Agenus
Zacks · 07/03 11:31
What Makes Agenus (AGEN) a Strong Momentum Stock: Buy Now?
Zacks · 06/26 17:00
U.S. debut on horizon for iTeos Therapeutics
Seeking Alpha - Article · 06/25 16:10
Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?
Is (AGEN) Outperforming Other Medical Stocks This Year?
Zacks · 06/25 15:30
Agenus' Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in Agenus.
Zacks · 06/25 12:47
Cramer Weighs In On Halliburton, AstraZeneca And More
Benzinga · 06/24 21:53
Cramer Weighs In On Halliburton, AstraZeneca And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said that Taiwan Semiconductor Mfg. Co. Ltd. (NYSE: TSM) is a great stock.
Benzinga · 06/24 20:53
The Charts of Agenus Need More Development
TheStreet.com · 06/24 17:35
贝达药业6500万美元获得两款II期临床抗体药大中华区权益!
药融圈 · 06/24 02:00
Cramer's lightning round: Two thumbs up for AstraZeneca
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
CNBC.com · 06/23 23:13
Agenus Stock Up on Licensing Deal With China-Based Firm
Zacks · 06/23 15:34
布局肿瘤免疫治疗方向热门靶点 贝达药业与美国Agenus达成合作
证券日报 · 06/23 11:47
深市上市公司公告(6月23日)
东方财富网 · 06/22 14:45
【公告速递】蓝光发展和嘉欣丝绸拟大额回购;多家公司半年报业绩大幅预增
中国证券网 · 06/22 14:13
Agenus Cell Therapy, Checkpoint Antibody Combinations Show Curative Preclinical Efficacy At AACR Meeting
LEXINGTON, Mass., June 22, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ:AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapy, adjuvants, and vaccines designed to
Benzinga · 06/22 13:47